参考文献/References:
[1] 王 朔,宋鉴清.肝病患者中血清胱抑素C测定的临床观察及意义[J].中国误诊学杂志,2011,11(21):5123.
Wang S, Song JQ. Clinical observation and clinical significance ofdetermination of serum cystatin C in patients with liver diseases[J].Chin JMisdiagnostics,2011,11(21):5123.
[2] 魏 星.肝病患者血清胱抑素C测定的临床意义[J].河北中医,2013,35(7):1114-1115.
Wei X.Clinical significance of determination of serum cystatin C inpatients with liver diseases[J].Hebei J TCM,2013,35(7):1114-1115.
[3] 赵永杰,鲁 岚.慢性乙肝患者血清Cys C浓度与肝功五项指标关系研究[J].国际检验医学杂志,2013,34(23):3256,插Ⅱ.
Zhao YJ,Lu L.To study the relationship between serum cystatin C concentration and five indicators of liver function in patients with chronic hepatitis B[J].Int J Lab Med,2013,34(23):3256,putⅡ.
[4] 中华医学会肝病学分会,中华医学会感染病分会.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24.
Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guidelines for prevention and treatmentof chronic hepatitis B(2010 Edition)[J].J Clin Hepatol,2011,19(1):13-24.
[5] 姚新洁,甄 萍,杜红利,等.糖皮质激素对血清胱抑素C表达的影响[J].现代检验医学杂志,2011,26(5):105-106,109.
Yao XJ,Zhen P,Du HL,et al.Influence of glucocorticoids on serumcystatin C expression[J].J Mod Lab Med,2011,26(5):105-106,109.
[6] 中华医学会肝病学分会和感染病学分会.病毒性肝炎防治方案(2000年版)[J].中国预防医学杂志,2000,1(1):44-52.
Chinese Society of Hepatology and Chinese Society of Infectious Disease.Viral hepatitis prevention plan(2000 Edition)[J].Chin Prev Med,2000,1(1):44-52.
[7] 全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. Chinese eGFR Investigation Collaboration.Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease[J].Chin J Nephrol,2006,22(10):589-595.
[8] Iyer S,Wei S,Brew K,et al.Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1[J].J Biol Chem,2007,282(1):364-371.
[9] 曾广智,谭宁华,贾锐锐,等.组织蛋白酶及其抑制剂研究进展[J].云南植物研究,2005,27(4):337-354.
Zeng GZ,Tan NH,Jia RR,et al.Cathepsins structures functionsand inhibitors[J].Acta Botanica Yunnanica,2005,27(4):337-354.
[10] 李 晖,杨永锐,杨晓冬,等.慢性乙型肝炎患者血浆脂氧素A4水平与疾病临床分度的关系研究[J].昆明医科大学学报,2014,35(2):80-82.
Li H,Yang YR,Yang XD,et al.Correlation of se-rum lipoxin A4 with clinical grading of chronic hepatitis B patients[J].Journal of Kunming Medical University,2014,35(2):80-82.
相似文献/References:
[1]惠凌云,王 凌,张 琳,等.CHB患者疾病进程与抑郁症的程度及血清BDNF水平的相关性[J].现代检验医学杂志,2015,30(03):13.[doi:10.3969/j.issn.1671-7414.2015.03.004]
HUI Ling-yun,WANG Ling,ZHANG Lin,et al.Correlation of the Disease Process,Depression
Severity and Serum Levels of BDNF in Patient with CHB[J].Journal of Modern Laboratory Medicine,2015,30(04):13.[doi:10.3969/j.issn.1671-7414.2015.03.004]
[2]张允奇a,陆学东b,张银辉b,等.SLE患者血清胱抑素C与血脂的相关性分析[J].现代检验医学杂志,2015,30(04):63.[doi:10.3969/j.issn.1671-7414.2015.04.017]
ZHANG Yun-qia,LU Xue-dongb,ZHANG Yin-huib,et al.Correlation Analysis of Serum Cystatin C and Lipids
Levels in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2015,30(04):63.[doi:10.3969/j.issn.1671-7414.2015.04.017]
[3]李步荣,张彤,李丽华,等.CHB患者HBV基因型及耐药突变基因联合检测临床研究[J].现代检验医学杂志,2015,30(05):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
LI Bu-rong,ZHANG Tong,LI Li-hua,et al.Clinical Study of Combined Detection about Hepatitis B Virus Genotypes
and Drug Resistant Mutation Genes in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2015,30(04):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
[4]徐晓嵘a,章晓鹰a,张珏a,等.干扰素治疗慢性乙型肝炎HBeAg血清学转换预测指标价值比较[J].现代检验医学杂志,2015,30(05):146.[doi:10.3969/j.issn.1671-7414.2015.05.046]
XU Xiao-ronga,ZHANG Xiao-yinga,ZHANG Juea,et al.Comparison of the Values for Predicting HBeAg Seroconversion
in the Treatment of Chronic Hepatitis B by PEG-IFN[J].Journal of Modern Laboratory Medicine,2015,30(04):146.[doi:10.3969/j.issn.1671-7414.2015.05.046]
[5]杨渝伟,黄玉霞,陈小红,等.胱抑素C及其eGFR方程在诊断肝硬化患者肾损害中的应用[J].现代检验医学杂志,2016,31(04):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
YANG Yu-wei,HUANG Yu-xia,CHEN Xiao-hong,et al.Clinical Application of Cystatin C and It's eGFR Equation
for Diagnosing Kidney Injure in Patients with Liver Cirrhosis[J].Journal of Modern Laboratory Medicine,2016,31(04):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
[6]高 科,陶 娟,范 宁,等.联合检测三种生化指标对糖尿病肾病早期诊断的临床价值分析[J].现代检验医学杂志,2016,31(04):117.[doi:10.3969/j.issn.1671-7414.2016.04.033]
GAO Ke,TAO Juan,FAN Ning,et al.Analysis of Combined Detection of Three Kinds of Biochemical
Indexes of Clinical Value for Early Diagnosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(04):117.[doi:10.3969/j.issn.1671-7414.2016.04.033]
[7]朱 娜a,张利侠b,张 华b,等.血清四项生化指标联合检测在狼疮肾炎患者早期肾损伤的临床意义[J].现代检验医学杂志,2017,32(02):114.[doi:10.3969/j.issn.1671-7414.2017.02.031]
ZHU Naa,ZHANG Li-xiab,ZHANG Huab,et al.Clinical Significance of Serum
Bun,Cr,Cys C and RBP Combined Detection
for Early Diagnosis of Renal Damage in Patlents with Lupus Nephritis[J].Journal of Modern Laboratory Medicine,2017,32(04):114.[doi:10.3969/j.issn.1671-7414.2017.02.031]
[8]王 坤,贾兴旺,董 矜,等.血清脂蛋白相关磷脂酶A2和胱抑素C联合检测对SLE患者并发狼疮性肾炎的风险评估[J].现代检验医学杂志,2017,32(04):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
WANG Kun,JIA Xing-wang,DONG Jin,et al.Risk Assessment of Combined Detection of Lipoprotein Associated
Phospholipase A2 and Cystatin C for Lupus Nephritis
in Patients with Systemic Lupus Erythematosus[J].Journal of Modern Laboratory Medicine,2017,32(04):6.[doi:10.3969/j.issn.1671-7414.2017.04.002]
[9]王福玲.血清miR-122,ALT及HBV-DNA定量检测对慢性乙型肝炎患者诊断的意义[J].现代检验医学杂志,2017,32(04):67.[doi:10.3969/j.issn.1671-7414.2017.04.019]
WANG Fu-ling.Diagnostic Value of Serum miR-122,ALT and HBV-DNA
in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2017,32(04):67.[doi:10.3969/j.issn.1671-7414.2017.04.019]
[10]黄太宏,徐学静,胡 伟,等.慢性乙型肝炎患者外周血IL-37的表达水平及意义[J].现代检验医学杂志,2017,32(06):26.[doi:10.3969/j.issn.1671-7414.2017.06.001]
HUANG Tai-hong,XU Xue-jing,HU Wei,et al.Expression and Clinical Significance of Blood IL-37
in Patients with Chronic HBV[J].Journal of Modern Laboratory Medicine,2017,32(04):26.[doi:10.3969/j.issn.1671-7414.2017.06.001]